The metallothionein and RCAS1 expression analysis in breast cancer and adjacent tissue regarding the immune cells presence and their activity
- PMID: 17187007
The metallothionein and RCAS1 expression analysis in breast cancer and adjacent tissue regarding the immune cells presence and their activity
Abstract
Introduction: The generation of proper immune response in the tumor environment seems to be essential in antitumor defense. RCAS1 expression has been shown to participate in the regulation of immune cytotoxic activity, metallothionein participates in the protection of cells against immune mediated apoptosis. Since MT and RCAS1 expression is observed within healthy tumor environment we aimed to focus on the proteins expression in tumor and its healthy adjacent tissue in invasive ductal breast cancer regarding the immune cells presence and activity.
Material and methods: RCAS1, metallothionein, CD3, CD56, CD4, CD25, CD69, CD68 and CD16 antigens expression was assessed by immunohistochemistry in invasive ductal breast cancer. Tissue samples were obtained from 45 patients and were grouped according to the presence of lymph nodes metastases. Two groups were obtained: with and without lymph nodes metastases.
Results: Significant differences were observed in RCAS1 and metallothionein expression in tumor and significant differences in metallothionein expression in healthy stroma regarding the presence of lymph nodes metastases. The significantly higher RCAS1 expression was noticed in tumor in comparison to stroma in patients with the presence of lymph nodes metastases. No such difference was observed in patients without the metastases. Significantly higher metallothionein expression was identified in tumor than in stroma in both groups of patients, with and without lymph nodes metastases. These changes in RCAS1 and metallothionein expression were significantly related with the changes in the number and activity of immune cells.
Conclusion: RCAS1 and metallothionein expression in breast cancer healthy stroma seems to be essential for the coexistence of cytotoxic immune cells and normal epithelial cells. The loss of the ability to compensate the growing cytotoxic immune response in the environment might participate in the development of tumor spread.
Similar articles
-
The characterization of the exposure to immune mediated apoptosis and the regulation of immune cytotoxic activity in the environment of a neoplasm and in decidua.Neuro Endocrinol Lett. 2006 Dec;27(6):779-85. Neuro Endocrinol Lett. 2006. PMID: 17187008
-
Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, endometrial adenocarcinoma and endometrium according to menstrual cycle changes.Gynecol Oncol. 2005 Dec;99(3):622-30. doi: 10.1016/j.ygyno.2005.07.003. Epub 2005 Aug 19. Gynecol Oncol. 2005. PMID: 16112719
-
Cycle dependent RCAS1 expression with respect to the immune cells presence and activity.Neuro Endocrinol Lett. 2006 Oct;27(5):645-50. Neuro Endocrinol Lett. 2006. PMID: 17159823
-
RCAS1, MT, and vimentin as potential markers of tumor microenvironment remodeling.Am J Reprod Immunol. 2010 Mar 1;63(3):181-8. doi: 10.1111/j.1600-0897.2009.00803.x. Epub 2010 Jan 19. Am J Reprod Immunol. 2010. PMID: 20085563 Review.
-
Significance of RCAS1 antigen in hepatocellular, cholangiocellular and pancreatic carcinomas.J Gastroenterol Hepatol. 2005 Aug;20(8):1143-8. doi: 10.1111/j.1440-1746.2005.03840.x. J Gastroenterol Hepatol. 2005. PMID: 16048560 Review.
Cited by
-
The Potential Role of MT and Vimentin Immunoreactivity in the Remodeling of the Microenvironment of Parotid Adenocarcinoma.Cancer Microenviron. 2010 Dec 15;4(1):105-13. doi: 10.1007/s12307-010-0058-z. Cancer Microenviron. 2010. PMID: 21505565 Free PMC article.
-
Clinical significance of tumor-associated antigen RCAS1 expression in human pancreatic ductal adenocarcinoma.Dig Dis Sci. 2008 Jun;53(6):1728-34. doi: 10.1007/s10620-007-0035-7. Dig Dis Sci. 2008. PMID: 17932753
-
The roles of metallothioneins in carcinogenesis.J Hematol Oncol. 2018 Aug 23;11(1):107. doi: 10.1186/s13045-018-0645-x. J Hematol Oncol. 2018. PMID: 30139373 Free PMC article. Review.
-
Analysis of metallothionein and vimentin immunoreactivity in pharyngeal squamous cell carcinoma and its microenvironment.Cell Tissue Res. 2013 May;352(2):341-9. doi: 10.1007/s00441-013-1566-1. Epub 2013 Feb 9. Cell Tissue Res. 2013. PMID: 23397427 Free PMC article.
-
Tumor cell cytoplasmic metallothionein expression associates with differential tumor immunogenicity and prognostic outcome in high-grade serous ovarian carcinoma.Front Oncol. 2023 Nov 8;13:1252700. doi: 10.3389/fonc.2023.1252700. eCollection 2023. Front Oncol. 2023. PMID: 38023247 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials